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Human mitochondrial outer membrane protein mitoNEET is a newly discovered target of type II
diabetes drug pioglitazone. Structurally, mitoNEET is a homodimer with each monomer
containing an N-terminal transmembrane alpha helix tethered to mitochondrial outer membrane
and a C-terminal cytosolic domain hosting a redox active [2Fe-2S] cluster. Genetic studies have
shown that mitoNEET has a central role in regulating energy metabolism in mitochondria.
However, specific function of mitoNEET remains largely elusive. Here we find that the
mitoNEET [2Fe-2S] clusters can be efficiently reduced by Escherichia coli thioredoxin reductase
and glutathione reductase in an NADPH-dependent reaction. Purified human glutathione reductase
has the same activity as E. coli thioredoxin reductase and glutathione reductase to reduce the
mitoNEET [2Fe-2S] clusters. However, rat thioredoxin reductase, a human thioredoxin reductase
homolog that contains selenocysteine in the catalytic center, has very little or no activity to reduce
the mitoNEET [2Fe-2S] clusters. N-ethylmaleimide, a potent thiol modifier, completely inhibits
human glutathione reductase to reduce the mitoNEET [2Fe-2S] clusters, indicating that the redox
active disulfide in the catalytic center of human glutathione reductase may be directly involved in
reducing the mitoNEET [2Fe-2S] clusters. Additional studies reveal that the reduced mitoNEET
[2Fe-2S] clusters in mouse heart cell extracts can be reversibly oxidized by hydrogen peroxide
without disruption of the clusters, suggesting that the mitoNEET [2Fe-2S] clusters may undergo
redox transition to regulate energy metabolism in mitochondria in response to oxidative signals.
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INTRODUCTION
Thiazolidinediones (TZDs) such as pioglitazone are prescription drugs for patients with type
II diabetes [1]. While the primary target of TZDs is the peroxisome proliferator-activated
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receptor γ (PPARγ) which regulates the expression of the genes for fatty acid metabolism
and insulin signaling pathways [2], TZDs also have the PPARγ-independent physiological
effects on energy metabolism in mitochondria [3]. This observation led to the discovery of a
novel mitochondrial outer membrane protein mitoNEET which specifically binds
pioglitazone [4]. Deletion of mitoNEET in mice decreases the oxidative phosphorylation
capacity in mitochondria [5]. On the other hand, increased expression of mitoNEET in
adipocytes enhances lipid uptake and storage and inhibits mitochondrial iron transport into
the matrix [6], suggesting that mitoNEET may regulate energy metabolism in mitochondria
[4]. Recent studies further showed that mitoNEET has a central role in development of
neurodegenerative diseases [7], breast cancer proliferation [8], TNFα-induced necroptosis in
hepatocytes [9], and browning of white adipose tissue [10], among other pathological
conditions [11].
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Human mitoNEET is a homodimer with each monomer containing an N-terminal
transmembrane α-helix (residues 14 to 32) tethered to mitochondrial outer membrane [5]
and a C-terminal cytosolic domain hosting a redox active [2Fe-2S] cluster via the unusual
ligand arrangement of three cysteine (Cys-72, Cys-74 and Cys-83) and one histidine
(His-87) residues [12–15]. While the specific function of mitoNEET has not been fully
understood, several studies have suggested that mitoNEET may transfer its [2Fe-2S] clusters
to apo-ferredoxin in vitro [16, 17] or to the iron regulatory protein-1 (IRP-1) in vivo [18].
Since mitochondria are the primary sites for iron-sulfur cluster biogenesis [19], it was
compelling to suggest that mitoNEET may act as a carrier transporting iron-sulfur clusters
assembled in mitochondria to target proteins in cytoplasm [16–18]. Nevertheless, the
observed cluster transfer occurs only when the mitoNEET [2Fe-2S] clusters are in oxidized
state [16]. Since the redox midpoint potential of the mitoNEET [2Fe-2S] clusters (Em7) is 0
mV [20, 21] and the cytosolic redox potential is ~ −325 mV (pH 7.0) [22], the mitoNEET
[2Fe-2S] clusters are mostly in the reduced state in cells under normal physiological
conditions [23]. Thus, mitoNEET may transfer its iron-sulfur clusters to target proteins only
when cells are under oxidative stress conditions [16].

Author Manuscript

Alternatively, mitoNEET may directly regulate energy metabolism in mitochondria via its
redox active [2Fe-2S] clusters [20, 23]. It has already been reported that the redox property
of the mitoNEET [2Fe-2S] clusters can be modulated by pH [21], inter-domain interactions
[24, 25], hydrogen bond network [26], type II diabetes drug pioglitazone [20], and NADP+/
NADPH [17, 27]. Recent proteomic studies further suggested that mitoNEET may form
complexes with proteins that are crucial in aging, diabetes, and neurodegenerative diseases
[28, 29]. Thus, the mitoNEET [2Fe-2S] cluster may act as a sensor of multiple cellular
signals to regulate mitochondrial functions via specific protein-protein interactions. In
previous studies, we reported that the mitoNEET [2Fe-2S] clusters are fully reduced when
expressed in Escherichia coli cells, and that purified mitoNEET [2Fe-2S] clusters can be
reduced by dithiothreitol or the E. coli thioredoxin/thioredoxin reductase system [23].
However, specific components that reduce or oxidize the mitoNEET [2Fe-2S] clusters in
mammalian cells have not been identified. Here, we find that human mitoNEET [2Fe-2S]
clusters can be efficiently reduced by E. coli thioredoxin reductase and glutathione reductase
in an NADPH-dependent reaction. Purified human glutathione reductase [30] has the same
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activity as E. coli glutathione reductase to reduce the mitoNEET [2Fe-2S] clusters.
However, rat thioredoxin reductase, a human thioredoxin reductase homolog that contains
an unusual selenocysteine residue (U498) in the catalytic center [31–33], has very little or no
activity to reduce the mitoNEET [2Fe-2S] clusters. N-ethylmaleimide, a potent modifier of
redox active thiols in human glutathione reductase [34], completely inhibits the enzyme to
reduce the mitoNEET [2Fe-2S] clusters, indicating that the redox active disulfide in the
catalytic center of human glutathione reductase may be directly involved in reducing the
mitoNEET [2Fe-2S] clusters. Additional studies show that the reduced mitoNEET [2Fe-2S]
clusters in the mouse heart cell extracts can be reversibly oxidized by hydrogen peroxide.
The results led us to propose that the mitoNEET [2Fe-2S] clusters may act as a novel redox
sensor to modulate energy metabolism in mitochondria in response to oxidative signals.

MATERIALS AND METHODS
Author Manuscript

1. Protein preparation
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A DNA fragment encoding human mitoNEET33–108 (containing amino acid residues 33–
108) was synthesized (Genscript co) and cloned into pET28b+. Recombinant mitoNEET
was expressed in E. coli BL21/DE3 strain and purified as described previously [23, 35]. E.
coli thioredoxin reductase [36], glutathione reductase [37], succinic semialdehyde
dehydrogenase [38], and 2,4-dienoyl-CoA reductase [39] were prepared using the E. coli
strains from the ASKA library [40]. Recombinant human glutathione reductase was
prepared using plasmid pUB302 (kindly provided by Professor Katja Becker, Justus Liebig
University, Germany) in an E. coli strain SG5 (in which gene gor encoding glutathione
reductase was deleted) [41]. Briefly, E. coli strain SG5 cells hosting pUB302 were grown in
LB media at 37°C for 5 hours without inducers, harvested, and disrupted by passing through
French press once. The crude cell extracts were centrifuged at 12,000g for 30 min at 4°C to
remove cell debris. Supernatant was dialyzed against 20 mM Tris for 5 hours at 4°C. The
dialyzed sample was added with 1 mM oxidized glutathione (GSSG), and loaded onto an
ADP-Sepharose column and washed with 0.3 M NaCl. Human glutathione reductase was
then eluted from the column with 0.8 M NaCl. The purity of purified proteins was greater
than 95% as judged by electrophoresis analysis on a 15% polyacrylamide gel containing
SDS followed by staining with Coomassie Blue. The protein concentrations of human
mitoNEET, E. coli thioredoxin reductase, E. coli glutathione reductase, and human
glutathione reductase were measured at 280 nm using an extinction coefficient of 8.6 mM−1
cm−1, 17.7 mM−1 cm−1, 38.2 mM−1 cm−1, and 34.9 mM−1 cm−1, respectively. Native rat
liver thioredoxin reductase was purchased from Sigma. Recombinant rat thioredoxin
reductase (containing native selenocysteine in the catalytic center) [42] was purchased from
Cayman Chemical.
2. Cell extracts preparation from E. coli cells and mouse heart
Wild type E. coli cells (BL21/DE3) were grown in LB media at 37°C under aerobic
conditions to OD at 600 nm of 1.0. Cells were harvested, washed with buffer containing
NaCl (500 mM) and Tris (20 mM, pH 8.0), and passed through French press once. After
centrifugation at 8,000 × g for 30 min at 4°C to remove cell debris, supernatant was loaded
onto Hi-Trap Desalting column (GE Lifesciences). For the mouse heart cell extracts, hearts
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from wild-type mice (C57BL/6J, 3–4 weeks old, obtained from the Pennington Biomedical
Research Center, Louisiana State University) were cleaned in PBS buffer and minced with
scissors. Heart tissues were ground with a homogenizer and further disrupted by drawing
and ejecting samples using a syringe with a 26-gauge needle. Cell debris were removed by
centrifugation at 8,000 × g for 20 min at 4°C, and the supernatant was used for the
experiments. The protein concentration of the prepared cell extracts was determined using
Bradford assay [43].
3. Analyses of the redox state of the mitoNEET [2Fe-2S] clusters
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Purified human mitoNEET dissolved in buffer containing NaCl (500 mM) and Tris (20 mM,
pH 8.0) in a sealed vial was purged with pure argon gas for 15 min. The prepared cell
extracts or enzymes were also purged with pure argon gas before transferred to the sealed
vials using a gas-tight Hamilton syringe. The reaction solutions were then incubated in a
37°C water bath for the indicated time before the samples were analyzed by using the
Beckman DU640 UV-visible spectrometer or EPR (Electron Paramagnetic Resonance). For
the NEM (N-ethylmaleimide) treatments, purified human glutathione reductase or the mouse
heart cell extracts were pre-incubated with NEM (2 mM) and NADPH (0.2 mM) at room
temperature for 30 min to block the redox active monothiols in the proteins.
4. EPR measurements
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The X-band EPR (Electron Paramagnetic Resonance) spectra were recorded using a Bruker
model ESR-300 spectrometer equipped with an Oxford Instruments 910 continuous flow
cryostat. Routine EPR conditions were: microwave frequency, 9.47 GHz; microwave power,
10.0 mW; modulation frequency, 100 kHz; modulation amplitude, 1.2 mT; temperature, 30
K; receive gain, 2×105. The amount of the reduced mitoNEET [2Fe-2S] clusters was
quantified as in [23].
5. Chemicals
Isopropyl β-D-1-thiogalactopyranoside, NADPH, kanamycin, ampicillin, and dithiothreitol
were purchased from Research Product International co. Reduced glutathione, oxidized
glutathione, N-ethylmaleimide, hydrogen peroxide, and other chemicals were purchased
from Sigma co.

RESULTS
1. Reduction of the mitoNEET [2Fe-2S] clusters by E. coli thioredoxin reductase and
glutathione reductase

Author Manuscript

When recombinant human mitoNEET was expressed in E. coli cells, the mitoNEET
[2Fe-2S] clusters were fully reduced [23], indicating that E. coli cells have a robust activity
to reduce the mitoNEET [2Fe-2S] clusters. To search for the cellular components that are
responsible for reducing the human mitoNEET [2Fe-2S] clusters, we prepared cell extracts
from exponentially growing E. coli cells. Figure 1A shows that while NADPH (spectrum 2)
or the E. coli cell extracts (spectrum 3) had no activity to reduce the human mitoNEET
[2Fe-2S] clusters, addition of NADPH to the cell extracts quickly reduced the mitoNEET
[2Fe-2S] clusters (spectrum 4) which had a typical rhombic EPR (Electron Paramagnetic
Free Radic Biol Med. Author manuscript; available in PMC 2016 April 01.
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Resonance) signal at g = 1.94 [12, 23, 26]. The amplitude of the EPR signal at g = 1.94 of
the mitoNEET [2Fe-2S] clusters in the E. coli cell extracts (spectrum 4) was essentially the
same as that when the mitoNEET protein was reduced with sodium dithionite (spectrum 5),
indicating that the mitoNEET [2Fe-2S] clusters are fully reduced in the E. coli cell extracts
by NADPH.
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Since the mitoNEET [2Fe-2S] clusters can be reduced by excess dithiothreitol in vitro [23],
we reasoned that the mitoNEET [2Fe-2S] clusters may be reduced by reduced thioredoxin
[23] or the enzymes that contain redox active disulfide in vivo. In E. coli, there are at least
two reductases: thioredoxin reductase [44] and glutathione reductase [37], that have a redox
active disulfide in the catalytic center. To test this idea, we prepared E. coli thioredoxin
reductase and glutathione reductase as described in the Materials and Methods. Purified E.
coli thioredoxin reductase and glutathione reductase had a similar UV-visible absorption
spectrum (Figure 1B), indicative of the protein-bound FAD as reported previously [37, 44].
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Figure 1C shows that purified E. coli thioredoxin reductase (spectrum 3) or glutathione
reductase (spectrum 4) had no activity to reduce the mitoNEET [2Fe-2S] clusters. However,
when mitoNEET was incubated with E. coli thioredoxin reductase and NADPH (spectrum
5) or E. coli glutathione reductase and NADPH (spectrum 6) at 37°C for 20 min under
anaerobic conditions, the mitoNEET [2Fe-2S] clusters were fully reduced, suggesting that
both E. coli thioredoxin reductase and glutathione reductase are able to reduce the
mitoNEET [2Fe-2S] clusters in the presence of NADPH. In parallel, we also prepared two
NADPH-dependent reductases: succinic semialdehyde dehydrogenase [38] and 2,4-dienoylCoA reductase [39] from E. coli cells. Both enzymes use NADPH as substrate but do not
contain the redox active disulfide in the catalytic center. Under the same experimental
conditions, E. coli succinic semialdehyde dehydrogenase and 2,4-dienoyl-CoA reductase
had no activity to reduce the mitoNEET [2Fe-2S] clusters in the presence of NADPH (data
not shown). Thus, E. coli thioredoxin reductase and glutathione reductase have the specific
activity in reducing the human mitoNEET [2Fe-2S] clusters.
2. Reduction of the mitoNEET [2Fe-2S] clusters by human glutathione reductase
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In humans, there are three thioredoxin reductases: a cytosolic form [45], a mitochondrial
form [46], and a thioredoxin glutathione reductase in the microsomal fraction of testis tissue
[47]. As mitoNEET localizes on mitochondrial outer membrane [5], it is most likely that
cytosolic thioredoxin reductase would be responsible for reducing the mitoNEET [2Fe-2S]
clusters. Like E. coli thioredoxin reductase, human cytosolic thioredoxin reductase contains
FAD and an NADPH binding site [32, 33, 48]. However, unlike E. coli thioredoxin
reductase, human thioredoxin reductase has an unusual selenocysteine residue (U498) in the
catalytic center [31–33]. As native human cytosolic thioredoxin reductase was not readily
available, we used rat thioredoxin reductase which has 91% identity and 96% similarity to
human thioredoxin reductase and contains the selenocysteine residue in the catalytic center.
Rat liver thioredoxin reductase (from Sigma) was fully active to reduce 5,5´-dithiobis-(2nitrobenzoic acid). However, unlike E. coli thioredoxin reductase, rat liver thioredoxin
reductase had very little or no activity to reduce the mitoNEET [2Fe-2S] clusters (data not
shown). We also obtained recombinant rat thioredoxin reductase (from Cayman Chemical)
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which also contains the selenocysteine residue and is fully active to reduce 5,5´-dithiobis-(2nitrobenzoic acid) (DTNB) [42]. Again, recombinant rat thioredoxin reductase failed to
reduce the mitoNEET [2Fe-2S] clusters in the presence of NADPH (Figure 2B, spectrum 2).
Human glutathione reductase is a major cellular reductase to reduce the oxidized glutathione
in cytosol [30, 41]. Unlike human thioredoxin reductase, human glutathione reductase does
not have selenocysteine in the catalytic center. We thus prepared recombinant human
glutathione reductase from E. coli cells following the procedures described in [41]. Purified
human glutathione reductase had a similar UV-visible absorption spectrum as E. coli
glutathione reductase (Figure 2A), and similar activity to reduce the mitoNEET [2Fe-2S]
clusters in the presence of NADPH (Figure 2B, spectra 3 and 4). Thus, in human cells, at
least glutathione reductase is able to reduce the mitoNEET [2Fe-2S] clusters in an NADPHdependent reaction.
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Pioglitazone, a type II diabetes drug, has been shown to shift the redox midpoint potential
(Em7) of the mitoNEET [2Fe-2S] clusters by ~ −100 mV [20]. The negative shift of the Em7
value would make it hard to reduce the mitoNEET [2Fe-2S] clusters. It would be of interest
to know whether pioglitazone may affect the human glutathione reductase-mediated
reduction of the mitoNEET [2Fe-2S] clusters. In the experiments, mitoNEET was preincubated with pioglitazone before being reduced with human glutathione reductase and
NADPH. As shown in Figure 2B, the mitoNEET [2Fe-2S] clusters was only partially
inhibited (spectrum 5) upon binding of pioglitazone. The result is consistent with the notion
that binding of pioglitazone to mitoNEET negatively shifts the Em7 of the mitoNEET
[2Fe-2S] clusters [20, 23] and impedes reduction of the mitoNEET [2Fe-2S] clusters by
glutathione reductase.
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The oxidized mitoNEET [2Fe-2S] clusters have two major UV-visible absorption peaks at
458 nm and 540 nm [12]. When the mitoNEET [2Fe-2S] clusters are reduced, the absorption
peak at 458 nm is changed to 420 nm [23]. Here we took advantage of the distinct UVvisible absorption peaks of the mitoNEET [2Fe-2S] clusters to explore the reduction kinetics
of the mitoNEET [2Fe-2S] clusters by human glutathione reductase. When mitoNEET was
incubated with a catalytic amount of human glutathione reductase in the presence of
NADPH at 37°C under anaerobic conditions, the absorption peak at 458 nm of the oxidized
mitoNEET [2Fe-2S] clusters was quickly decreased and replaced with the absorption peak at
420 nm of the reduced mitoNEET [2Fe-2S] clusters (Figure 3A). The amount of the reduced
mitoNEET [2Fe-2S] clusters in the reaction solution was plotted as a function of incubation
time. Under the experimental conditions, the mitoNEET [2Fe-2S] clusters were fully
reduced in 20 min with a half reduction time of less than 5 min (Figure 3B).
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3. The redox active disulfide center in human glutathione reductase is involved in reducing
the mitoNEET [2Fe-2S] clusters
Human glutathione reductase catalyzes the reduction of oxidized glutathione (GSSG) to
reduced glutathione (GSH) using NADPH as electron donor [30, 41]. If glutathione
reductase reduces the mitoNEET [2Fe-2S] clusters at the same catalytic site where GSSG is
reduced, we would expect competition between GSSG and the mitoNEET [2Fe-2S] clusters
for the catalytic center in the enzyme. To test this idea, we explored the effect of GSSG on
Free Radic Biol Med. Author manuscript; available in PMC 2016 April 01.
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the glutathione reductase-mediated reduction of the mitoNEET [2Fe-2S] clusters. Figure 4A
shows that in the absence of GSSG, the mitoNEET [2FE-2S] clusters (10 µM) were fully
reduced by 10 µM NADPH in the presence of a catalytic amount of human glutathione
reductase. In the presence of 10 µM GSSG, however, the mitoNEET [2Fe-2S] clusters were
reduced only after 20 µM NADPH was added in the incubation solution (Figure 4B). Thus,
GSSG may effectively block the human glutathione reductase-mediated reduction of the
mitoNEET [2Fe-2S] clusters by competing for the same catalytic center in the enzyme
(Figure 4C).
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Unlike E. coli thioredoxin reductase and glutathione reductase (Figure 1C) or human
glutathione reductase (Figure 2B), rat thioredoxin reductase has very little or no activity to
reduce the mitoNEET [2Fe-2S] clusters (Figure 2B). One possible explanation is that rat
thioredoxin reductase has an unusual selenocysteine in the catalytic center [31–33], which
fails to reduce the mitoNEET [2Fe-2S] clusters. If that is the case, we would expect that
modification of the redox active disulfide in the catalytic center of human glutathione
reductase may inhibit the enzyme activity to reduce the mitoNEET [2Fe-2S] clusters.
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N-ethylmaleimide (NEM), a potent thiol modifier, has been used to inhibit human
glutathione reductase [34, 49]. Figure 4D shows that the NEM-treated human glutathione
reductase failed to reduce the mitoNEET [2Fe-2S] clusters (spectrum 2). However, addition
of sodium dithionite to the above reaction solution quickly restored the EPR signal at g =
1.94 of the mitoNEET [2Fe-2S] clusters (spectrum 3), suggesting that NEM inhibits human
glutathione reductase to reduce the mitoNEET [2Fe-2S] clusters without directly modifying
the mitoNEET [2Fe-2S] clusters. Thus, the redox active disulfide in the catalytic center of
human glutathione reductase may be directly involved in in reducing the mitoNEET
[2Fe-2S] clusters.
5. The mitoNEET [2Fe-2S] clusters are fully reduced in the mouse heart cell extracts by
NADPH
As human glutathione reductase can efficiently reduce the mitoNEET [2Fe-2S] clusters in
an NADPH-dependent reaction (Figure 3), the mitoNEET [2Fe-2S] clusters may also be
reduced in mammalian cells by glutathione reductase or similar enzymes. To test this idea,
we prepared cell extracts from mouse heart as described in the Materials and Methods.
Figure 5A shows that while the mouse heart cell extracts had no activity to reduce the
mitoNEET [2Fe-2S] clusters (spectrum 2), addition of NADPH to the cell extracts reduced
the mitoNEET [2Fe-2S] clusters (spectrum 3) with the EPR amplitude similar to that
reduced with sodium dithionite (spectrum 4).
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The cell extracts were then treated with the thiol modifier NEM to inactivate glutathione
reductase or similar enzymes. As shown in Figure 5B, the NEM-treated cell extracts had no
activity to reduce the mitoNEET [2Fe-2S] clusters in the presence of NADPH (spectrum 3).
Nevertheless, addition of sodium dithionite to the NEM-treated cell extracts immediately
restored the EPR signal at g = 1.94 of the reduced mitoNEET [2Fe-2S] clusters (spectrum
4), suggesting that NEM inhibits the cellular reductase activities without affecting on the
mitoNEET [2FE-2S] clusters in the mouse heart cell extracts.
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6. Reduced mitoNEET [2Fe-2S] clusters in the cell extracts are transiently oxidized by
hydrogen peroxide
To examine whether the mitoNEET [2Fe-2S] clusters may undergo redox transition in
response to oxidative signals, we treated mouse heart cell extracts containing the prereduced mitoNEET [2Fe-2S] clusters with different amounts of hydrogen peroxide. As the
concentration of hydrogen peroxide in the cell extracts was increased from 0 to 200 µM, the
reduced mitoNEET [2Fe-2S] clusters were gradually oxidized (Figure 6A). About 100 µM
hydrogen peroxide was sufficient to completely oxidize 5 µM mitoNEET [2Fe-2S] clusters
in the cell extracts (Figure 6B). Importantly, addition of sodium dithionite to the hydrogen
peroxide-treated cell extracts quickly restored the EPR signal at g = 1.94 of the reduced
mitoNEET [2Fe-2S] clusters (Figure 6A), suggesting that hydrogen peroxide oxidizes the
mitoNEET [2Fe-2S] clusters without disrupting the clusters in the protein.
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We then asked whether oxidation of the mitoNEET [2Fe-2S] clusters by hydrogen peroxide
is reversible in the mouse heart cell extracts. In the experiment, the mitoNEET [2Fe-2S]
clusters oxidized by hydrogen peroxide in the cell extracts with excess NADPH were reincubated at 37°C under anaerobic conditions. As shown in Figure 7, the oxidized
mitoNEET [2Fe-2S] clusters in the cell extracts were almost fully re-reduced after about 30
min re-incubation.

DISCUSSION
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Human mitoNEET is a small mitochondrial outer membrane protein containing a redox
active [2Fe-2S] cluster. Here we find that the mitoNEET [2Fe-2S] clusters can be efficiently
reduced by human glutathione reductase in an NADPH-dependent reaction. On the other
hand, rat thioredoxin reductase, a homolog of human thioredoxin reductase, has very little or
no activity to reduce the mitoNEET [2Fe-2S] clusters. Oxidized glutathione appears to
compete for the catalytic site of human glutathione reductase and effectively inhibits the
enzyme-mediated reduction of the mitoNEET [2Fe-2S] clusters, indicating a potential
dynamic link between the redox state of the mitoNEET [2Fe-2S] clusters and the ratio of
oxidized glutathione to reduced glutathione in cells. Additional studies further revealed that
the reduced mitoNEET [2Fe-2S] clusters in the mouse heart cell extracts can be transiently
oxidized by hydrogen peroxide without disruption of the clusters in the protein. The results
suggest that the mitoNEET [2Fe-2S] clusters may undergo redox transition to regulate
energy metabolism in mitochondria in response to oxidative signals.
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The finding that human glutathione reductase [30] can reduce the mitoNEET [2Fe-2S]
clusters (Figure 2B) is novel. While the underlying mechanism is not immediately clear, it
seems that the redox active disulfide in the catalytic center of human glutathione reductase
has a crucial role in reducing the mitoNEET [2Fe-2S] clusters. Both E. coli thioredoxin
reductase [44] and glutathione reductase [37] contain redox active disulfide in the catalytic
center and have the same activity to reduce the mitoNEET [2Fe-2S] clusters (Figure 1). In
contrast, rat thioredoxin reductase, a homolog of human thioredoxin reductase that contains
an unusual selenocysteine in the catalytic center [31–33], has very little or no activity to
reduce the mitoNEET [2Fe-2S] clusters (Figure 2B). E. coli succinic semialdehyde
dehydrogenase [38] and 2,4-dienoyl-CoA reductase [39], which use NADPH as substrate
Free Radic Biol Med. Author manuscript; available in PMC 2016 April 01.
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but do not have a redox active disulfide in the catalytic center, also fail to reduce the
mitoNEET [2Fe-2S] clusters (data not shown). Furthermore, modification of the redox
active disulfide in human glutathione reductase by thiol modifier NEM [34, 49] completely
inhibits the enzyme activity to reduce the mitoNEET [2Fe-2S] clusters (Figures 4 and 5).
Taken together, we conclude that the redox active disulfide in the catalytic center of human
glutathione reductase may be directly involved in reducing the mitoNEET [2Fe-2S] clusters
(Figure 8).
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While the mechanism for reduction of disulfide by iron-sulfur cluster in proteins has been
extensively investigated in plant ferredoxin-thioredoxin reductase [50], the reverse reaction
(reduction of iron-sulfur cluster in proteins by dithiol) is essentially unknown. Interestingly,
Fridovich’s group previously reported that E. coli thioredoxin reductase may produce
superoxide by transferring a single electron to dioxygen [51]. Perhaps, E. coli thioredoxin
reductase utilizes similar mechanism to reduce the mitoNEET [2Fe-2S] clusters (Figure 1C).
More recently, Buckel’s group showed that butyryl-CoA dehydrogenase from
Acidaminococcus fermentans, a FAD-containing enzyme, can reduce the ferredoxin
[4Fe-4S] cluster and crotonyl-CoA simultaneously [52] in a bifurcation reaction [53]. FAD
acts as an electron gate to deliver one electron at a time for reduction of the ferredoxin
[4Fe-4S] cluster and crotonyl-CoA in butyryl-CoA dehydrogenase [52]. As human
glutathione reductase also contains FAD (Figure 2A), we propose that during the reaction
cycle, an intermediate state of FADH- coupled with the redox active disulfide formed in
human glutathione reductase [30] may deliver single electrons to reduce the mitoNEET
[2Fe-2S] clusters (Figure 8).
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Under normal physiological conditions, the mitoNEET [2Fe-2S] clusters are mostly in
reduced state in vivo [23] (Figure 5). However, when cells are under oxidative stress or
during apoptosis and differentiation, the intracellular redox potential could increase from
−325 mV (pH 7.0) [22] to as high as +200 mV [54], which would result in oxidation of the
mitoNEET [2Fe-2S] clusters. The closest distance between two [2Fe-2S] clusters in the
mitoNEET dimer is about 14 Å [13–15]. Thus, oxidation of the two [2Fe-2S] clusters in the
mitoNEET dimer may result in confirmation change of the mitoNEET dimer via electric
repulsion. Since mitoNEET can potentially form protein complexes with E3 ubiquitin ligase
Parkin [28], V-ATPase [29], tax-responsive enhancer element-binding protein 107 (RPL6)
[29], translocase of outer mitochondrial membrane 7 homolog (TOMM7) [29],
mitochondrial outer membrane import complex protein 1 (MTX1) [29], polyubiquitin-C
(UBC) [55], and glutamate dehydrogenase 1 [56], we postulate that mitoNEET may
modulate the functions of its binding partners in mitochondria via redox transition of its
[2Fe-2S] clusters in response to redox signals.
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MitoNEET-like proteins are widely distributed in the three domains of life [57–59]. In
humans, there are two mitoNEET-like proteins: Miner1 [60] and Miner2 [5]. Like
mitoNEET, the C-terminal domain of Miner1 hosts a redox active [2Fe-2S] cluster via three
cysteine and one histidine residues [60]. Mutations in Miner1 have been attributed to
Wolfram Syndrome 2, a disease characterized by juvenile onset diabetes mellitus and optic
atrophy [61]. Miner1 was initially localized on endoplasmic reticulum [61], but recent
studies indicated that Miner1 also localizes on mitochondrial outer membrane [62, 63] and
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has a crucial role in regulating sulfhydryl redox status, the unfold protein response, and Ca2+
homeostasis in mitochondria via a yet unknown regulatory mechanism [63]. While the
physiological function of Miner2 remains unknown, Miner2 is also a mitochondrial outer
membrane protein [5] hosting two [2Fe-2S] clusters per monomer (unpublished results). It
may be envisioned that human mitoNEET, Miner1 and Miner2 may modulate different
functions in mitochondria via redox transition of the [2Fe-2S] clusters.
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Figure 1. The mitoNEET [2Fe-2S] clusters are reduced by E. coli thioredoxin reductase and
glutathione reductase

Author Manuscript

A), EPR spectra of the mitoNEET [2Fe-2S] clusters in the E. coli cell extracts. Purified
mitoNEET (10 µM of [2Fe-2S] clusters) (spectrum 1) was incubated with NADPH (50 µM)
(spectrum 2), the E. coli cell extracts (4 mg/ml of total protein) (spectrum 3), or NADPH (50
µM) and the E. coli cell extracts (4 mg/ml of total protein) (spectrum 4) at 37°C for 20 min
under anaerobic conditions. Spectrum 5, purified mitoNEET (10 µM of [2Fe-2S] clusters)
reduced with 2 mM sodium dithionite. The EPR signal at g = 1.94 represents the reduced
mitoNEET [2Fe-2S] clusters. B), purified E. coli thioredoxin reductase and glutathione
reductase. Spectrum 1, UV-visible absorption spectra of purified E. coli thioredoxin
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reductase (eTrxB). Spectrum 2, UV-visible absorption spectra of purified glutathione
reductase (eGor). eTrxB and eGor shown in B) contained about 15 µM of FAD. Insert is a
photograph of the SDS-PAGE of purified E. coli thioredoxin reductase (lane 1) and
glutathione reductase (lane 2). C), reduction of the mitoNEET [2Fe-2S] clusters by E. coli
thioredoxin reductase and glutathione reductase. Purified mitoNEET (10 µM of [2Fe-2S]
clusters) (spectrum 1) was incubated with NADPH (50 µM) (spectrum 2), E. coli
thioredoxin reductase (eTrxB) (1 µM) (spectrum 3), E. coli glutathione reductase (eGor) (1
µM) (spectrum 4), E. coli thioredoxin reductase (1 µM) and NADPH (50 µM) (spectrum 5),
or E. coli glutathione reductase (1 µM) and NADPH (50 µM) (spectrum 6) at 37°C for 20
min under anaerobic conditions. The EPR signal at gav = 1.94 represents the reduced
mitoNEET [2Fe-2S] clusters. The results are the representatives of three independent
experiments.
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Figure 2. Reduction of the mitoNEET [2Fe-2S] clusters by human glutathione reductase
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A), UV-visible absorption spectra of purified E. coli glutathione reductase (eGor) and
human glutathione reductase (hGSR). Each protein shown in A) contained about 15 µM of
FAD. B), reduction of the mitoNEET [2Fe-2S] clusters by human cytosolic glutathione
reductase. A mix of purified mitoNEET (10 µM of [2Fe-2S] clusters) and NADPH (100 µM)
(spectrum 1) was incubated with rat thioredoxin reductase (0.5 µM) (spectrum 2), E. coli
glutathione reductase (eGor) (0.5 µM) (spectrum 3), human glutathione reductase (hGSR)
(0.5 µM) (spectrum 4) at 37°C for 20 min under anaerobic conditions. Spectrum 5, a mix of
mitoNEET (10 µM of [2Fe-2S] clusters) and NADPH ( 100 µM) was pre-incubated with
pioglitazone (2.5 mM) at room temperature for 30 min before being reduced with human
glutathione reductase (0.5 µM). The results are the representatives of three independent
experiments.
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Figure 3. Reduction kinetics of the mitoNEET [2Fe-2S] clusters by human glutathione reductase
(hGSR)

Author Manuscript

A), reduction of (the mitoNEET [2Fe-2S] clusters by human glutathione reductase. Purified
mitoNEET (10 µM of [2Fe-2S] clusters) was incubated with hGSR (1 µM) and NADPH (20
µM) at 37°C under anaerobic conditions. Spectra were taken at 0, 2, 5, 10, 20, and 30 min
after hGSR was added to the reaction solution. The absorption peak at 458 nm represents the
oxidized mitoNEET [2Fe-2S] clusters, and the peak at 420 nm represents the reduced
mitoNEET [2Fe-2S] clusters. B), reduction kinetics of the mitoNEET [2Fe-2S] clusters by
hGSR. The spectra in A) were deconvoluted to the reduced and oxidized mitoNEET
[2Fe-2S] clusters using KaleidaGraph. The percentage of the oxidized mitoNEET [2Fe-2S]
clusters was plotted as a function of incubation time. The results are the representatives of
three independent experiments.
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Figure 4. The redox active disulfide in human glutathione reductase is crucial for reducing the
mitoNEET [2Fe-2S] clusters

A), reduction of the mitoNEET [2Fe-2S] clusters by human glutathione reductase without
the oxidized glutathione. Purified mitoNEET (10 µM of [2Fe-2S] clusters) was incubated
with 0, 5, 10, and 20 µM NADPH and hGSR (0.5 µM) at 37°C for 20 min under anaerobic
conditions. The samples were subjected to the UV-Visible absorption measurements. B),
same as in A) except 10 µM GSSG was incubated in each reaction solution. C), effect of
GSSG on reduction of the mitoNEET [2Fe-2S] clusters. The amount of the reduced
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mitoNEET [2Fe-2S] clusters was plotted as a function of NADPH in the incubation solution.
Closed circles, no GSSG. Closed squares, with 10 µM GSSG. D), inhibition of human
glutathione reductase by NEM (N-ethylmaleimide). Purified hGSR was pre-incubated with
or without NEM (2 mM) at room temperature for 3 hours. MitoNEET was then incubated
with NADPH (20 µM) and hGSR (0.5 µM) (spectrum 1) or NADPH (20 µM) and the NEMtreated hGSR (0.5 µM) (spectrum 2) at 37°C for 20 min under anaerobic conditions.
Spectrum 3, mitoNEET incubated with the NEM-treated hGSR and NADPH was reduced
with sodium dithionite (2 mM). The results are the representatives of three independent
experiments.
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Figure 5. The mitoNEET [2Fe-2S] clusters are reduced in the mouse heart cell extracts by
NADPH
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A), reduction of the mitoNEET [2Fe-2S] clusters in the mouse heart cell extracts. Purified
mitoNEET (10 µM of [2Fe-2S] clusters) (spectrum 1) was incubated with the mouse heart
cell extracts (2 mg/ml of total protein) (spectrum 2), or the mouse heart cell extracts
supplemented with NADPH (100 µM) (spectrum 3) at 37°C for 20 min under anaerobic
conditions. Spectrum 4, mitoNEET mixed with the mouse heart cell extracts was treated
with sodium dithionite (2 mM) under anaerobic conditions. Spectrum 5, the mouse heart cell
extracts were incubated with NADPH without exogenous human mitoNEET. The EPR
signal at g = 1.94 represents the reduced mitoNEET [2Fe-2S] clusters. B), inhibition of the
NADPH-mediated reduction of the mitoNEET [2Fe-2S] clusters by N-ethylmaleimide
(NEM). The mouse heart cell extracts were pre-treated with 0 mM (spectrum 2), and 2 mM
(spectrum 3) NEM at room temperature for 3 hours. Purified mitoNEET (10 µM [2Fe-2S]
clusters) mixed with NADPH (100 µM) (spectrum 1) was then incubated with the NEMpretreated cell extracts for 20 min at 37°C under anaerobic conditions. Spectrum 4,
mitoNEET after incubation with the NEM-pretreated cell extracts and NADPH was reduced
with sodium dithionite (2 mM). The results are the representative of at least three
independent experiments.

Free Radic Biol Med. Author manuscript; available in PMC 2016 April 01.

Landry et al.

Page 22

Author Manuscript
Author Manuscript
Figure 6. Hydrogen peroxide-mediated oxidation of the mitoNEET [2Fe-2S] clusters in the cell
extracts

Author Manuscript

A), oxidation of the mitoNEET [2Fe-2S] clusters in the cell extracts by H2O2. Purified
mitoNEET (5 µM of [2Fe-2S] clusters) in the mouse heart cell extracts (1 mg/mL of total
protein) pre-reduced with NADPH (100 µM) was treated with 0 µM (spectrum 1), 20 µM
(spectrum 2), 50 µM (spectrum 3), 100 µM (spectrum 4), and 200 µM (spectrum 5) H2O2 for
5 min. Spectrum 6, the mitoNEET treated with 200 µM H2O2 was immediately reduced with
sodium dithionite (2 mM). B), titration of hydrogen peroxide in the incubation solution. The
amplitudes of the EPR signal at g = 1.94 of the reduced mitoNEET [2Fe-2S] clusters were
plotted as a function of the H2O2 concentration in the cell extracts. The results are the
representative from three independent experiments.
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Figure 7. Re-reduction of the mitoNEET [2Fe-2S] clusters in the cell extracts after hydrogen
peroxide exposure
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A), re-reduction of the mitoNEET [2Fe-2S] clusters in the cell extracts. Purified mitoNEET
(5 µM of [2Fe-2S] clusters) was incubated with NADPH (2 mM) and the mouse heart cell
extracts (1 mg/mL of total protein) at 37°C for 15 min under anaerobic conditions (spectrum
1). The pre-reduced mitoNEET [2Fe-2S] clusters in the cell extracts were treated with 100
µM hydrogen peroxide for 5 min (spectrum 2), and re-incubated at 37°C under anaerobic
conditions for 10 min (spectrum 3), 20 min (spectrum 4), and 30 min (spectrum 5). B), time
course of re-reduction of the mitoNEET [2Fe-2S] clusters in the cell extracts by NADPH
after the hydrogen peroxide treatment. The amplitudes of the EPR signal at g = 1.94 were
plotted as a function of time after addition of H2O2 to the incubation solution. The tesults
are the representatives of three independent experiments.
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Figure 8. A proposed model for redox transition of the mitoNEET [2Fe-2S] clusters in response
to hydrogen peroxide in mammalian cells

Cytosolic reductases (e.g. glutathione reductase) transfer electrons from NADPH to FAD to
form FADH− which in turn transfers single electron to reduce the mitoNEET [2Fe-2S]
clusters. When cells are subjected to oxidative stress, the reduced mitoNEET [2Fe-2S]
clusters are reversibly oxidized by hydrogen peroxide.
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